CoChat

Temporal inhibition of autophagy reveals segmental reversal of ageing with increased cancer risk

Open access

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Abstract

Autophagy is an important cellular degradation pathway with a central role in metabolism as well as basic quality control, two processes inextricably linked to ageing. A decrease in autophagy is associated with increasing age, yet it is unknown if this is causal in the ageing process, and whether autophagy restoration can counteract these ageing effects. Here we demonstrate that systemic autophagy inhibition induces the premature acquisition of age-associated phenotypes and pathologies in mammals. Remarkably, autophagy restoration provides a near complete recovery of morbidity and a significant extension of lifespan; however, at the molecular level this rescue appears incomplete. Importantly autophagy-restored mice still succumb earlier due to an increase in spontaneous tumour formation. Thus, our data suggest that chronic autophagy inhibition confers an irreversible increase in cancer risk and uncovers a biphasic role of autophagy in cancer development being both tumour suppressive and oncogenic, sequentially.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-019-14187-x

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Autophagy inhibition decreases lifespan. LT-Atg5i mice on dox continuously from 2 months old display a reduced lifespan in comparison with LT-Control as shown in survival graphs for combined (p < 0.0001) (a), male (p < 0.0001) (b), female (p < 0.0001) (c) (Mantel–Cox test). Median survival (days on dox) and mice per group are indicated. During this period LT-Atg5i mice also display a reduced weight gain in both male (d) and female (e) cohorts. f LT-Atg5i mice also display an increased frequency of skin inflammation and eye infections in comparison with age-matched LT-Control mice. g Cardiac fibrosis was also evident in LT-Atg5i mice. Representative images of H&E and Massons Trichrome are shown. Scale bars, 100 μm. h Age-matched skinned mice. LT-Atg5i mice show kyphosis (yellow dotted line traces the arch of the spine). They often displayed premature greying (dotted rectangle). Arrows indicate the presence of inflammation.
Fig. 1 Autophagy inhibition decreases lifespan. LT-Atg5i mice on dox continuously from 2 months old display a reduced lifespan in comparison with LT-Control as shown in survival graphs for combined (p < 0.0001) (a), male (p < 0.0001) (b), female (p < 0.0001) (c) (Mantel–Cox test). Median survival (days on dox) and mice per group are indicated. During this period LT-Atg5i mice also display a reduced weight gain in both male (d) and female (e) cohorts. f LT-Atg5i mice also display an increased frequency of skin inflammation and eye infections in comparison with age-matched LT-Control mice. g Cardiac fibrosis was also evident in LT-Atg5i mice. Representative images of H&E and Massons Trichrome are shown. Scale bars, 100 μm. h Age-matched skinned mice. LT-Atg5i mice show kyphosis (yellow dotted line traces the arch of the spine). They often displayed premature greying (dotted rectangle). Arrows indicate the presence of inflammation.CC BY · PubMed Central
Fig. 2 LT-Atg5i mice present with accelerated aging phenotypes. a Extramedullary haematopoiesis is present in the spleens of LT-Atg5i mice in comparison with age-matched controls. Scale bars, 100 μm. b 6-month-old LT-Atg5i mice (4 months dox treatment) display increased White Blood Cell counts (WBC). Meanwhile, irradiated wild-type mice in receipt of uninduced bone marrow from Ctrl or Atg5i mice display a reduced WBC count after 4 months of dox treatment (unpaired two-tailed Welches t test, n = 5–6 per group). c Composition of the peripheral immune system in LT-Atg5i mice is reminiscent of old control mice (n = 5–6 mice per group). d 6-month-old LT-Atg5i mice (4 months dox treatment) displayed increased serum levels of IL-6 and TNF (LT-Atg5i n = 5, LT-Ctrl n = 7; Mann Whitney Test). e Bone marrow transplantation of uninduced Ctrl and Atg5i bone marrow into irradiated wild-type recipient mice after 4 months of dox treatment Atg5i recipient mice display a myeloid skewing. LT-Atg5i mice display alterations in skeletal muscle after 4-month of dox treatment. LT-Atg5i mice display a significant difference in cross-sectional area (f) (n = 3 R-Ctrl and 3 R-Atg5i, unpaired two-tailed Welch’s t test) and minimum feret size (g) (n = 3 R-Ctrl and 3 R-Atg5i, unpaired two-tailed Welch’s t test). LT-Atg5i mice also display a decrease in Pax7 nuclear positivity per fibre (h), an increase in central nucleation (i), and positivity for the mitochondrial marker TOM20 (j), as determined by tissue immunofluorescence (unpaired two-tailed Welches t test; n = 3 R-Ctrl and 3 R-Atg5i). Error bars indicate standard deviations. *p < 0.05; **p < 0.01, ***p < 0.001.
Fig. 2 LT-Atg5i mice present with accelerated aging phenotypes. a Extramedullary haematopoiesis is present in the spleens of LT-Atg5i mice in comparison with age-matched controls. Scale bars, 100 μm. b 6-month-old LT-Atg5i mice (4 months dox treatment) display increased White Blood Cell counts (WBC). Meanwhile, irradiated wild-type mice in receipt of uninduced bone marrow from Ctrl or Atg5i mice display a reduced WBC count after 4 months of dox treatment (unpaired two-tailed Welches t test, n = 5–6 per group). c Composition of the peripheral immune system in LT-Atg5i mice is reminiscent of old control mice (n = 5–6 mice per group). d 6-month-old LT-Atg5i mice (4 months dox treatment) displayed increased serum levels of IL-6 and TNF (LT-Atg5i n = 5, LT-Ctrl n = 7; Mann Whitney Test). e Bone marrow transplantation of uninduced Ctrl and Atg5i bone marrow into irradiated wild-type recipient mice after 4 months of dox treatment Atg5i recipient mice display a myeloid skewing. LT-Atg5i mice display alterations in skeletal muscle after 4-month of dox treatment. LT-Atg5i mice display a significant difference in cross-sectional area (f) (n = 3 R-Ctrl and 3 R-Atg5i, unpaired two-tailed Welch’s t test) and minimum feret size (g) (n = 3 R-Ctrl and 3 R-Atg5i, unpaired two-tailed Welch’s t test). LT-Atg5i mice also display a decrease in Pax7 nuclear positivity per fibre (h), an increase in central nucleation (i), and positivity for the mitochondrial marker TOM20 (j), as determined by tissue immunofluorescence (unpaired two-tailed Welches t test; n = 3 R-Ctrl and 3 R-Atg5i). Error bars indicate standard deviations. *p < 0.05; **p < 0.01, ***p < 0.001.CC BY · PubMed Central
Fig. 3 Autophagy inhibition drives senescence in vivo. Markers of senescence can also be seen across multiple tissues in our LT-Atg5i cohorts treated with dox for 4 months including in kidney (a), heart (b), and liver (c). LT-Atg5i livers stain positively for senescence associated β-galactosidase and p21 unlike age-matched control mice (d) (scale bar, 25 μm). e 6-month doxycycline treated LT-Atg5i livers display an increase in the frequency and abundance of γ-H2AX at telomeres, a marker associated with increasing chronological age (unpaired two-tailed t test; n = 5). f A representative example image shown. Arrowheads point to TAF that are magnified on the right of the image. Scale bar, 10 μm. Error bars indicate standard deviation ***p < 0.001. For a–c source data are provided as a Source Data file.
Fig. 3 Autophagy inhibition drives senescence in vivo. Markers of senescence can also be seen across multiple tissues in our LT-Atg5i cohorts treated with dox for 4 months including in kidney (a), heart (b), and liver (c). LT-Atg5i livers stain positively for senescence associated β-galactosidase and p21 unlike age-matched control mice (d) (scale bar, 25 μm). e 6-month doxycycline treated LT-Atg5i livers display an increase in the frequency and abundance of γ-H2AX at telomeres, a marker associated with increasing chronological age (unpaired two-tailed t test; n = 5). f A representative example image shown. Arrowheads point to TAF that are magnified on the right of the image. Scale bar, 10 μm. Error bars indicate standard deviation ***p < 0.001. For a–c source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 4 Restoration of autophagy partially restores health-span. a Schematic of R-Atg5i study. Briefly 2-month old mice are given dox to induce Atg5 downregulation for 4 months at which point they exhibit ageing-like phenotypes. Dox is then removed and autophagy restored. b Liver and kidney tissues from R-Atg5i mice with autophagy restored for 4 months display evidence of Atg5 protein and autophagic flux restoration, yet the liver still stains positively for the marker of senescence p16. c Atg5i mice on dox for 4 months and 6 months display increase frailty scores in comparison with controls (ARU, arbitrary units). While R-Atg5i mice where autophagy has been restored for 4 months, display a recovery (Two-way ANOVA with Tukey’s correction for all comparisons, n = 3–16). d Whole blood cell counts from R-Atg5i mice display no difference in comparison with age matched R-Control mice (unpaired two-tailed t test; n = 11 per group). e Inflammatory serum cytokines IL-6 and TNF are equivalent in R-Atg5i and R-Control mice 2-months post dox removal (Mann Whitney test; n = 3 R-Ctrl and 4 R-Atg5i). f Red blood cell distribution width (RDW) is unaltered in LT-Ctrl and LT-Atg5i cohorts (unpaired two-tailed t test; n = 3 per group), yet appears increased in autophagy-restored cohorts in comparison with age-matched littermate control mice (4 months dox, 8 months restoration) (unpaired two-tailed t test; n = 14 per group). Error bars indicate standard deviation; NS denotes not significant. *p < 0.05; **p < 0.01, ***p < 0.001. For b source data are provided as a Source Data file.
Fig. 4 Restoration of autophagy partially restores health-span. a Schematic of R-Atg5i study. Briefly 2-month old mice are given dox to induce Atg5 downregulation for 4 months at which point they exhibit ageing-like phenotypes. Dox is then removed and autophagy restored. b Liver and kidney tissues from R-Atg5i mice with autophagy restored for 4 months display evidence of Atg5 protein and autophagic flux restoration, yet the liver still stains positively for the marker of senescence p16. c Atg5i mice on dox for 4 months and 6 months display increase frailty scores in comparison with controls (ARU, arbitrary units). While R-Atg5i mice where autophagy has been restored for 4 months, display a recovery (Two-way ANOVA with Tukey’s correction for all comparisons, n = 3–16). d Whole blood cell counts from R-Atg5i mice display no difference in comparison with age matched R-Control mice (unpaired two-tailed t test; n = 11 per group). e Inflammatory serum cytokines IL-6 and TNF are equivalent in R-Atg5i and R-Control mice 2-months post dox removal (Mann Whitney test; n = 3 R-Ctrl and 4 R-Atg5i). f Red blood cell distribution width (RDW) is unaltered in LT-Ctrl and LT-Atg5i cohorts (unpaired two-tailed t test; n = 3 per group), yet appears increased in autophagy-restored cohorts in comparison with age-matched littermate control mice (4 months dox, 8 months restoration) (unpaired two-tailed t test; n = 14 per group). Error bars indicate standard deviation; NS denotes not significant. *p < 0.05; **p < 0.01, ***p < 0.001. For b source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 5 Restoration of autophagy does not reverse all markers of aging. a p62/Sqstm1 staining of R-Atg5i liver highlights the incomplete removal of aggregates 4 months after autophagy restoration. Scale bars, 100 μm. b The same livers have a higher incidence of age associated pigmentation in comparison with age-matched control mice. (yellow arrow). c TAF frequency and abundance also remains elevated in R-Atg5i mice (unpaired two-tailed t test; n = 4 R-Ctrl and 3 R-Atg5i). Skeletal muscle analysis from 4 months dox treated and 2 months restored R-Atg5i mice. R-Atg5i muscle fibres continue to display significant alterations in minimum feret size (d) (n = 3 R-Ctrl and 4 R-Atg5i, Mann Whitney test) and cross-sectional area (e) (n = 3 R-Ctrl and 4 R-Atg5i, Mann Whitney test). Whilst Pax7 nuclear positivity per fibre still displays no evidence of recovery (f), both central nucleation (g) and positivity for the mitochondrial marker Tom20 (h) exhibit levels similar to R-Ctrl mice. (f–h, unpaired two-tailed Welches t test; n = 3 R-Ctrl and 4 R-Atg5i). Error bars indicate standard deviations. *p < 0.05; **p < 0.01, ***p < 0.001.
Fig. 5 Restoration of autophagy does not reverse all markers of aging. a p62/Sqstm1 staining of R-Atg5i liver highlights the incomplete removal of aggregates 4 months after autophagy restoration. Scale bars, 100 μm. b The same livers have a higher incidence of age associated pigmentation in comparison with age-matched control mice. (yellow arrow). c TAF frequency and abundance also remains elevated in R-Atg5i mice (unpaired two-tailed t test; n = 4 R-Ctrl and 3 R-Atg5i). Skeletal muscle analysis from 4 months dox treated and 2 months restored R-Atg5i mice. R-Atg5i muscle fibres continue to display significant alterations in minimum feret size (d) (n = 3 R-Ctrl and 4 R-Atg5i, Mann Whitney test) and cross-sectional area (e) (n = 3 R-Ctrl and 4 R-Atg5i, Mann Whitney test). Whilst Pax7 nuclear positivity per fibre still displays no evidence of recovery (f), both central nucleation (g) and positivity for the mitochondrial marker Tom20 (h) exhibit levels similar to R-Ctrl mice. (f–h, unpaired two-tailed Welches t test; n = 3 R-Ctrl and 4 R-Atg5i). Error bars indicate standard deviations. *p < 0.05; **p < 0.01, ***p < 0.001.CC BY · PubMed Central
Fig. 6 R-Atg5i mice are associated with accelerated spontaneous tumour development. a R-Atg5i mice on display a reduced lifespan in comparison to R-Control mice (p < 0.01). b Increased frequency of spontaneous tumour formation in R-Atg5i cohorts (p < 0.001). c Tumour spectrum in R-Atg5i mice versus R-Control mice. d, e Examples of R-Atg5i tumour histology. H&E staining and immunostaining of indicated proteins. Scale bars, 100 μm.
Fig. 6 R-Atg5i mice are associated with accelerated spontaneous tumour development. a R-Atg5i mice on display a reduced lifespan in comparison to R-Control mice (p < 0.01). b Increased frequency of spontaneous tumour formation in R-Atg5i cohorts (p < 0.001). c Tumour spectrum in R-Atg5i mice versus R-Control mice. d, e Examples of R-Atg5i tumour histology. H&E staining and immunostaining of indicated proteins. Scale bars, 100 μm.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

5 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Cited by

See all 108

Metadata

Authors
Cassidy, L. D., Young, A. R. J., Young, C. N. J., Soilleux, E. J., Fielder, E., Weigand, B. M., Lagnado, A., Brais, R., Ktistakis, N. T., Wiggins, K. A., Pyrillou, K., Clarke, M. C. H., Jurk, D., Passos, J. F., & Narita, M.
Affiliations
  • University of Cambridge (GB)
  • Newcastle University (GB)
  • Mayo Clinic (US)
  • Cambridge University Hospitals NHS Foundation Trust (GB)
  • Babraham Institute (GB)
  • Tokyo Institute of Technology (JP)
Corresponding author
Narita, Masashi
Venue
Nature Communications
Published
2020-01-16
Volume
11
Issue
1
Pages
307-307
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3000127343
Cited by
108
References
48
Citations by year
2026: 12 · 2025: 18 · 2024: 19 · 2023: 14 · 2022: 14 · 2021: 16 · 2020: 15
FWCI
10.58
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Apollo (University of Cambridge) (submittedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • DMU Open Research Archive (De Montfort University) (submittedVersion)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • Apollo
  • Apollo (cc-by)
Funders
  • University of Michigan
  • Cancer Research UK (A20976, A17197, C14303, 30038, C20/A20976, 24453, 15890, C14303 / A17197, 15890, 24453)
  • British Heart Foundation (FS/18/56/34177, FS/13/3/30038, FS/18/19/33371, FS/18/56/34177A, RG/16/8/32388)
  • Academy of Medical Sciences
  • University of Cambridge
  • Newcastle University
  • Fakultet Medicinskih Nauka, Univerziteta U Kragujevcu
  • Medical Research Council (MR/M013049/1, MR/M013049, MR/R010013/1)
  • Biotechnology and Biological Sciences Research Council (BBS/E/B/000C0432, BBS/E/B/000C0433, BB/K017314/1, BBS/E/B/000C0413, BBS/E/B/000C0434, BB/H022384/1, BB/S013466/1)
  • Cancer Research UK Cambridge Institute, University of Cambridge (C14303, C14303/A17197, A17197)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords
autophagy, aging, lifespan extension, cancer risk, autophagy inhibition, tumor suppression, premature aging, quality control
MeSH terms
Autophagy-Related Protein 5, Sequestosome-1 Protein, Aging, Animals, Autophagy, Disease Models, Animal, Female, Inflammation, Longevity, Male, Mice, Inbred C57BL, Muscles, Neoplasms, Phenotype, Skin, Bone Marrow Transplantation, Mice, Knockout, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Temporal inhibition of autophagy reveals segmental reversal of ageing with increased cancer risk. https://app.cochat.ai/papers/10.1038/s41467-019-14187-x
The paper
Cassidy, L. D., Young, A. R. J., Young, C. N. J., Soilleux, E. J., Fielder, E., Weigand, B. M., Lagnado, A., Brais, R., Ktistakis, N. T., Wiggins, K. A., Pyrillou, K., Clarke, M. C. H., Jurk, D., Passos, J. F., & Narita, M. (2020). Temporal inhibition of autophagy reveals segmental reversal of ageing with increased cancer risk. Nature Communications. https://doi.org/10.1038/s41467-019-14187-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.